Clin2
NCT07135063Possibly a fitNot yet recruiting

Nerve function study in Behçet's disease

Behcet DiseaseCranial Nerve Disorder

Part of Brain & nervous system, Eyes & vision, Genetic & congenital, Heart & circulation, Mouth & dental, Skin clinical trials.

This study looks at how Behçet's disease affects cranial nerves (nerves in your head and face) and how that relates to your symptoms. It compares people with Behçet's to healthy volunteers to understand these nerve changes better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with Behçet's disease using the standard criteria.
  • You do not have other autoimmune or rheumatic conditions.
  • You have not had facial trauma, surgery, or radiation treatment.
  • You are not pregnant, and do not have a pacemaker or recent Botox in your jaw muscle.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06836817Not yet recruiting
How Behçet's disease affects the voice

This study compares the voice of people with Behçet's disease to healthy individuals. It aims to understand how Behçet's affects voice quality and speaking.

NCT07375940Recruiting
Understanding Behçet Disease in children and teens

This study looks at the health records and blood tests of children and young adults with Behçet disease to learn more about the condition. It also compares their results with healthy children to find clues that may help doctors better understand and treat Behçet disease.

Florence, Florence
NCT06451575Recruiting
Blood Clots and Behçet's Disease Study

This study looks at how Behçet's disease affects blood clotting. If you have Behçet's disease and are between 18–70, you may help doctors understand why some people with Behçet's develop dangerous blood clots.

Erzurum, Üniversite Mahallesi
NCT05845723Recruiting· Phase 2
Study drugs for blood-vessel Behçet’s to reduce inflammation

This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.

Beijing, Beijing Municipality
NCT07157189Not yet recruiting
Behçet's disease study in Assiut

This study looks at the symptoms, lab results, and treatments for people with Behçet's disease. It may help doctors better understand and manage the condition.

NCT06721234Recruiting
Vein thickness and inflammation in Behcet disease

This study looks at how the thickness of the femoral vein wall and certain markers of inflammation relate to Behcet disease. It may help doctors better understand and monitor the condition.

Sohag

Hear when a new Behcet Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.